Our offer.
THE BERLIN CENTER FOR GENE AND CELL THERAPIES BRINGS TOGETHER LAB CAPABILITIES, GMP MANUFACTURING FACILITIES, OFFICE SPACE, AND NETWORKING OPPORTUNITIES. A UNIQUE COMBINATION MADE AVAILABLE TO START-UPS FOR THE FIRST TIME IN EUROPE.

Embedded within the Berlin biotech ecosystem and providing access to the expertise of world-renowned public and private biomedical and healthcare facilities, the Berlin Center for Gene and Cell Therapies provides a creative and interactive hub for next-level innovations in gene and cell therapies.
We provide what it takes.
We help start-ups to translate their innovative research quickly and effectively, and enable the rapid availability of clinical trial study medications ready to test in the clinic.








Developed in cooperation with


The incubator area
- ~5,000 sqm of fully furnished and equipped, affordable, and ready-to-use labs and offices on demand
- ~1,000 sqm of joint working areas, conference rooms, and community areas
- Custom service agreements available for lab benches and desks, tailored to start-ups in the seed phase, Series A, and beyond
- Mentoring program covering entrepreneurship, business development, regulatory affairs, clinical development, and more

The manufacturing plant
- Preferential access for tenants of the incubator to the GMP-certified manufacturing site
- Focus on cell therapies (e.g. iPSCs, MSCs) and gene therapies (e.g. AAV, in-vivo genome editing, LNP/mRNA complex)
- 7 GMP manufacturing suites, classes C and B
- Analytical labs for development support and QC release testing
- Cutting-edge digital infrastructure to link lab and process data, as well as access to data science experts

Berlin is the place.
The vibrancy and creativity of Berlin are one-of-a-kind. Innovation comes natural to us. Berlin is home to a multitude of research institutions and hospitals, and home to one of the largest start-up scenes in Europe. Together with the rich pool of biotech professionals and entrepreneurs, this provides unequaled opportunities for collaborations and conducting clinical trials, which is crucial for the development and testing of new therapies and new medical devices.
Unique science and research landscape:
~40
Broad hospital network:
>88
Strong entrepreneurial culture:
~300



